Stocks
Health Care
gyre
Gyre Therapeutics
NASDAQ: GYRE
+0.36 (+4.56%)
8.26
USD
At close at Mar 04, 21:39 UTC
Income Statement
Revenue
105.76M
Gross Profit
101.87M
Operating Income
16.16M
Pretax Income
15.27M
Net Income
12.09M
EBITDA
19.64M
EBIT
17.41M
Earnings Per Share
0.14
Balance Sheet
Cash & Cash Equivalents
18.39M
Total Debt
1.41M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
94.75M
Book Value Per Share
1.06
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.